Ovid Therapeutics Inc. current ratio

The Current Ratio as of November 2026 (TTM) for Ovid Therapeutics Inc. (OVID) is 12.39

According to Ovid Therapeutics Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 12.39. This represents a change of 31.39% compared to the average of 9.43 of the last 4 quarters.

Ovid Therapeutics Inc. (OVID) Historical Current Ratio (quarterly & annually)

How has OVID Current Ratio performed in the past?

The mean historical Current Ratio of Ovid Therapeutics Inc. over the last ten years is 10.22. The current 12.39 Current Ratio has changed 21.23% with respect to the historical average. Over the past ten years (40 quarters), OVID's Current Ratio was at its highest in in the September 2016 quarter at 21.76. The Current Ratio was at its lowest in in the June 2020 quarter at 3.02.

Ovid Therapeutics Inc. (OVID) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Ovid Therapeutics Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Ovid Therapeutics Inc. (OVID) Average Current Ratio

How has OVID Current Ratio performed in the past?

The current Current Ratio of Ovid Therapeutics Inc. (OVID) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Ovid Therapeutics Inc. (OVID) Current Ratio vs. Peers

How is OVID’s Current Ratio compared to its peers?

Ovid Therapeutics Inc.’s Current Ratio is greater than Rocket Pharmaceuticals, Inc. (9.24), greater than Stoke Therapeutics, Inc. (7.24), greater than Ultragenyx Pharmaceutical Inc. (1.40), greater than Wave Life Sciences Ltd. (8.38), greater than MeiraGTx Holdings plc (3.76), greater than Neurogene Inc. (10.64), less than Taysha Gene Therapies, Inc. (17.76), less than Lexeo Therapeutics, Inc. Common Stock (13.89), greater than Voyager Therapeutics, Inc. (7.51), greater than Abeona Therapeutics Inc. (6.63),

Build a custom stock screener for Ovid Therapeutics Inc. (OVID) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ovid Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ovid Therapeutics Inc. (OVID) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ovid Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.